Marilena Vrana/LinkedIn
Jul 29, 2026, 10:42
Marilena Vrana: Your Voice Can Shape the Future of Plasma-Derived Medicines
Marilena Vrana, Vice President at the Plasma Protein Therapeutics Association (PPTA) Europe, shared on LinkedIn:
”Help share the conversation around plasma-derived medicines.
Every patient story, caregiver experience, and healthcare perspective help strengthen awareness, education, and advocacy for people who rely on plasma-derived medicines.
The global survey is available in 13 languages, takes just 5 minutes, and your participation can make a real difference.
If you haven’t already, I invite you to complete the survey and share it with your network.
Plasma Powers Possibility. Your voice powers progress.”
Proceed to the video attached to the post.
Stay updated with Hemostasis Today.
-
Nov 9, 2026, 13:48PF4-ELISA–Negative HIT: Are We Missing a New Class of Anti-PF4 Immunothrombotic Disease?
-
Nov 9, 2026, 13:07Nandini Sadasivam: Gene Therapy for Sickle Cell Disease and Thalassaemia
-
Nov 9, 2026, 13:04Raising Awareness of Bleeding Disorders in Women and Girls – EHC
-
Nov 9, 2026, 12:59Rahul Bohra: Exploring the Complex Mechanisms of Sickle Cell Disease
-
Nov 9, 2026, 12:53Three Years of Movement and Thrombosis Awareness in the Czech Republic – World Thrombosis day
-
Nov 9, 2026, 12:51Octavio Marques Pontes-Neto: Intensive Blood-Pressure Control Reduces Cardiovascular Events After Ischemic Stroke
-
Nov 9, 2026, 12:49Irma Bagdoniene: What Really Makes Us Live Longer
-
Nov 9, 2026, 12:47Imo Akpan: Announcing the 2027 Women’s Hematology Summit
-
Nov 9, 2026, 12:45Shadi Yaghi: Rethinking Antithrombotic Therapy After Stroke